[Physiologic and physiopathologic implications of insulin-receptor interaction (II). Pathologic situations in which changes in insulin-receptor interaction are detected].
D000052:Acanthosis Nigricans / Q000150:complications; D000818:Animals; D001645:Biguanides / Q000494:pharmacology; D002648:Child; D048909:Diabetes Complications; D003922:Diabetes Mellitus, Type 1 / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000378:metabolism; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology; D007333:Insulin Resistance / Q000187:drug effects; D007340:Insulinoma / Q000378:metabolism; D008107:Liver Diseases / Q000378:metabolism; D051379:Mice; D009136:Muscular Dystrophies / Q000378:metabolism; D009765:Obesity / Q000378:metabolism; D011247:Pregnancy; D011254:Pregnancy in Diabetics / Q000378:metabolism; D051381:Rats; D011972:Receptor, Insulin / Q000378:metabolism* / Q000502:physiology; D013453:Sulfonylurea Compounds / Q000494:pharmacology
D001645:Biguanides; D007004:Hypoglycemic Agents; D013453:Sulfonylurea Compounds; D011972:Receptor, Insulin
Implicaciones fisiológicas y fisiopatológicas de la interacción insulina-receptor (II). Situaciones patológicas en las que se detectan modificaciones en la interacción insulina-receptor.